🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 6 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/05/2010 | 51,09 | 52,93 | 50,85 | 51,96 | +0,87% | 4,07% | 693.700 |
| 21/05/2010 | 50,41 | 51,92 | 50,20 | 51,51 | +1,46% | 3,41% | 1.612.700 |
| 20/05/2010 | 51,54 | 52,05 | 50,71 | 50,77 | -3,50% | 2,60% | 1.126.500 |
| 19/05/2010 | 53,37 | 53,65 | 52,54 | 52,61 | -1,90% | 2,08% | 683.900 |
| 18/05/2010 | 52,81 | 54,01 | 52,81 | 53,63 | +2,56% | 2,27% | 1.013.600 |
| 17/05/2010 | 51,74 | 52,54 | 51,40 | 52,29 | +1,57% | 2,20% | 640.800 |
| 14/05/2010 | 52,37 | 52,44 | 51,15 | 51,48 | -2,28% | 2,46% | 217.200 |
| 13/05/2010 | 53,78 | 53,80 | 52,57 | 52,68 | -1,94% | 2,29% | 322.200 |
| 12/05/2010 | 52,89 | 53,75 | 52,60 | 53,72 | +2,03% | 2,17% | 398.000 |
| 11/05/2010 | 52,83 | 53,34 | 52,56 | 52,65 | -1,18% | 1,48% | 394.600 |
| 10/05/2010 | 52,18 | 53,49 | 52,01 | 53,28 | +4,45% | 2,84% | 1.126.900 |
| 07/05/2010 | 52,91 | 53,70 | 50,77 | 51,01 | -3,48% | 5,54% | 1.141.200 |
| 06/05/2010 | 54,15 | 54,82 | 50,00 | 52,85 | -4,45% | 8,90% | 1.168.200 |
| 05/05/2010 | 54,32 | 55,46 | 52,45 | 55,31 | +0,20% | 5,54% | 945.200 |
| 04/05/2010 | 56,25 | 56,63 | 54,41 | 55,20 | -2,85% | 3,95% | 1.221.100 |
| 03/05/2010 | 56,77 | 57,25 | 56,07 | 56,82 | -0,12% | 2,08% | 840.300 |
| 30/04/2010 | 55,79 | 57,33 | 55,76 | 56,89 | +1,59% | 2,81% | 1.099.600 |
| 29/04/2010 | 55,41 | 57,69 | 54,96 | 56,00 | +2,43% | 4,93% | 2.423.800 |
| 28/04/2010 | 55,33 | 55,95 | 54,56 | 54,67 | -0,02% | 2,51% | 823.400 |
| 27/04/2010 | 54,44 | 55,60 | 54,18 | 54,68 | -0,15% | 2,61% | 1.064.000 |
| 26/04/2010 | 56,00 | 56,13 | 54,67 | 54,76 | -2,07% | 2,61% | 403.000 |
| 23/04/2010 | 55,97 | 56,02 | 55,26 | 55,92 | -0,45% | 1,36% | 626.100 |
| 22/04/2010 | 55,67 | 56,75 | 54,51 | 56,17 | +0,52% | 4,02% | 763.700 |
| 21/04/2010 | 58,56 | 58,56 | 55,05 | 55,88 | -4,17% | 5,99% | 1.865.600 |
| 20/04/2010 | 58,52 | 59,05 | 57,90 | 58,31 | -0,12% | 1,97% | 194.800 |
| 19/04/2010 | 58,01 | 59,22 | 57,71 | 58,38 | +0,57% | 2,60% | 377.900 |
| 16/04/2010 | 58,42 | 58,53 | 57,42 | 58,05 | -0,68% | 1,90% | 333.400 |
| 15/04/2010 | 58,04 | 58,79 | 57,35 | 58,45 | -0,12% | 2,48% | 399.100 |
| 14/04/2010 | 58,00 | 58,62 | 57,68 | 58,52 | +0,90% | 1,62% | 453.300 |
| 13/04/2010 | 57,16 | 58,45 | 56,97 | 58,00 | +1,63% | 2,59% | 560.200 |